Entera Bio ENTX
NASDAQ ENTX
$2.91 +0.22 (+8.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Other Non-Current Assets (2024 - 2026)

Updated

Entera Bio (ENTX) reported Other Non-Current Assets of $7.12 million for Q2 2026, down 11.1% from $8.02 million a year earlier and down 8.6% from the prior quarter.

Analysis

Entera Bio (ENTX) Other Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Entera Bio posted Other Non-Current Assets of $7.78 million.

  • By year, Other Non-Current Assets came in at $80,000 in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7.79 million (Q1 2026), $7.78 million (Q4 2025) and $8.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Entera Bio 143.43 Mn 112.31 Mn - 7.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.12 Mn
Mar 31, 2026 7.79 Mn
Dec 31, 2025 7.78 Mn
Sep 30, 2025 8.03 Mn
Jun 30, 2025 8.02 Mn
Mar 31, 2025 8.00 Mn
Dec 31, 2024 80,000.00
API Access

Entera Bio Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ENTX&period=max&api_key=YOUR_API_KEY